查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386123

狗疫苗市場報告：2030 年趨勢、預測和競爭分析

Dog Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

狗用疫苗的趨勢和預測

預計到 2030 年，全球狗疫苗市場將達到 46 億美元，2024 年至 2030 年複合年成長率為 5.7%。這個市場的主要驅動力是寵物狗數量的增加、狗飼主對狗的預防保健意識的提高以及政府有關疫苗接種的法規。全球狗疫苗市場前景廣闊，獸醫院/診所市場和寵物主人市場蘊藏商機。

狗疫苗市場洞察

Lucintel 預測，由於犬類感染疾病的增加以及與其他疫苗相比更方便、更有效的事實，活性減毒疫苗仍將是最大的區隔市場。

在這個市場中，預計獸醫院和診所將在預測期內實現高速成長。

由於政府對疫苗接種的嚴格規定，北美將繼續成為最大的地區，以保護狗免受嚴重疾病的侵害，同時保護生命免受狗咬傷。

市場規模/估計：狗疫苗的市場規模以金額估計（10 億美元）。

趨勢和預測分析：各個區隔市場和地區的市場趨勢（2018-2023）和預測（2024-2030）。

區隔分析：依類型、年齡、最終用途、地區和金額（十億美元）分析犬疫苗市場規模。

區域分析：北美、歐洲、亞太地區和世界其他地區狗疫苗市場的區域區隔。

成長機會：依犬疫苗類型、年齡、最終用途和地區進行成長機會分析。

策略分析：狗疫苗市場併購、新產品開發、競爭形勢等。

基於波特五力模型的產業競爭實力分析。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球狗用疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球狗疫苗市場趨勢（2018-2023）和預測（2024-2030）
  • 全球狗疫苗市場（依類型）
    • 減毒活病毒疫苗
    • 結合疫苗
    • 去活化疫苗
    • 次單位疫苗
    • 類毒素疫苗
    • DNA疫苗
    • 重組疫苗
  • 依年齡分類的全球狗疫苗市場
    • 少於6個月
    • 6個月或以上
  • 全球狗疫苗市場（依最終用途）
    • 獸醫醫院和診所
    • 寵物飼主
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球狗疫苗市場區域分佈
  • 北美狗疫苗市場
  • 歐洲狗疫苗市場
  • 亞太地區狗疫苗市場
  • 其他地區狗疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球狗疫苗市場成長機會
    • 依年齡分類的全球狗疫苗市場成長機會
    • 全球狗疫苗市場成長機會（依最終用途）
    • 全球狗疫苗市場成長機會（依地區）
  • 全球狗疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球狗疫苗市場產能擴張
    • 全球狗疫苗市場的併購、收購和合資合併
    • 認證和許可

第7章主要企業概況

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck
簡介目錄

Dog Vaccine Trends and Forecast

The future of the global dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets. The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030 with a CAGR of 5.7% from 2024 to 2030. The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

A more than 150-page report is developed to help in your business decisions.

Dog Vaccine by Segment

The study includes a forecast for the global dog vaccine by type, age, end use, and region.

Dog Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccine

Dog Vaccine Market by Age [Shipment Analysis by Value from 2018 to 2030]:

  • Below 6 Months
  • Above 6 Months

Dog Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Veterinary Hospitals & Clinics
  • Pet Owners
  • Others

Dog Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Dog Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies dog vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the dog vaccine companies profiled in this report include-

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck

Dog Vaccine Market Insights

Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Within this market, veterinary hospital & clinic is expected to witness higher growth over the forecast period.

North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Features of the Global Dog Vaccine Market

Market Size Estimates: Dog vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Dog vaccine market size by type, age, end use, and region in terms of value ($B).

Regional Analysis: Dog vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, ages, end uses, and regions for the dog vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the dog vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the dog vaccine market size?

Answer: The global dog vaccine market is expected to reach an estimated $4.6 billion by 2030.

Q.2 What is the growth forecast for dog vaccine market?

Answer: The global dog vaccine market is expected to grow with a CAGR of 5.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the dog vaccine market?

Answer: The major drivers for this market are increasing adoption of pet dogs, pet owners are becoming more aware of the benefits of preventive healthcare for their dogs, and government regulations for vaccinations.

Q4. What are the major segments for dog vaccine market?

Answer: The future of the dog vaccine market looks promising with opportunities in the veterinary hospital & clinic and pet owner markets.

Q5. Who are the key dog vaccine market companies?

Answer: Some of the key dog vaccine companies are as follows:

  • Bayer
  • Vetquinol
  • Boehringer Ingelhiem
  • Ceva
  • Eli Lilly
  • Heska
  • Merck

Q6. Which dog vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that attenuated live will remain the largest segment due to increasing infectious diseases among the dogs and it is more convenient and effective vaccines as compared to others.

Q7. In dog vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region due to strict government regulations regarding vaccination in protecting the dogs from serious diseases as well as protect human life from dog biting.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the dog vaccine market by type (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, dna vaccines, and recombinant vaccine), age (below 6 months and above 6 months), end use (veterinary hospitals & clinics, pet owners, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Dog Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Dog Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Dog Vaccine Market by Type
    • 3.3.1: Attenuated Live Vaccines
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Inactivated Vaccines
    • 3.3.4: Subunit Vaccines
    • 3.3.5: Toxoid Vaccines
    • 3.3.6: DNA Vaccines
    • 3.3.7: Recombinant Vaccine
  • 3.4: Global Dog Vaccine Market by Age
    • 3.4.1: Below 6 months
    • 3.4.2: Above 6 months
  • 3.5: Global Dog Vaccine Market by End Use
    • 3.5.1: Veterinary Hospitals & Clinics
    • 3.5.2: Pet Owners
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Dog Vaccine Market by Region
  • 4.2: North American Dog Vaccine Market
    • 4.2.2: North American Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.3: European Dog Vaccine Market
    • 4.3.1: European Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.3.2: European Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.4: APAC Dog Vaccine Market
    • 4.4.1: APAC Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.4.2: APAC Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others
  • 4.5: ROW Dog Vaccine Market
    • 4.5.1: ROW Dog Vaccine Market by Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccine
    • 4.5.2: ROW Dog Vaccine Market by End Use: Veterinary Hospitals & Clinics, Pet Owners, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Dog Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Dog Vaccine Market by Age
    • 6.1.3: Growth Opportunities for the Global Dog Vaccine Market by End Use
    • 6.1.4: Growth Opportunities for the Global Dog Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Dog Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Dog Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Dog Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bayer
  • 7.2: Vetquinol
  • 7.3: Boehringer Ingelhiem
  • 7.4: Ceva
  • 7.5: Eli Lilly
  • 7.6: Heska
  • 7.7: Merck